# PharMEDium Services, LLC. (NYSE: COMP), Cleveland, MS – FDA Inspections

Source: https://www.keypedia.com/companies/pharmedium-services-llc/73e690bd-fd92-406f-a783-a9ee0e9ad6d4

> Inspection records and compliance data for PharMEDium Services, LLC. in Cleveland, Mississippi. 4 FDA inspections on record (4 OAI), 1 Form 483, last inspected January 05, 2018. Publicly traded as NYSE: COMP.

---

## Details

- Name: PharMEDium Services, LLC.
- FEI Number: 3004153061
- Facility Type: drug manufacturer
- Address Line 1: 913 N Davis Ave
- City: Cleveland
- State: Mississippi
- Zip Code: 38732
- Country Name: United States
- Address: 913 N Davis Ave, Cleveland, Mississippi 38732, United States
- Country: United States

## Stock

- Stock ticker: COMP
- Exchange: NYSE
- Share price: $10.05
- Market cap: $7.7B
- Price as of: November 13, 2026

## Related Documents

- [FDA Inspection 1037359 - PharMEDium Services, LLC. - 2018-01-05](https://www.keypedia.com/records/fda_inspections/pharmedium-services-llc/398b2f65-c943-4a81-b223-0fa3f6b43870) — classification: Official Action Indicated (OAI), source: FDA, date: January 5, 2018
- [FDA Inspection 821901 - PharMEDium Services, LLC. - 2013-02-22](https://www.keypedia.com/records/fda_inspections/pharmedium-services-llc/654ae233-f41f-4fd2-a3f8-4a179ceca6a9) — classification: Official Action Indicated (OAI), source: FDA, date: February 22, 2013
- [FDA Inspection 607567 - PharMEDium Services, LLC. - 2009-08-17](https://www.keypedia.com/records/fda_inspections/pharmedium-services-llc/541942f2-d716-4d6a-b045-723986959f8c) — classification: Official Action Indicated (OAI), source: FDA, date: August 17, 2009
- [FDA Inspection 578362 - PharMEDium Services, LLC. - 2009-04-21](https://www.keypedia.com/records/fda_inspections/pharmedium-services-llc/98ed7e5e-d412-4a21-8127-4be77747e47e) — classification: Official Action Indicated (OAI), source: FDA, date: April 21, 2009
- [483 - PharMEDium Services, LLC. - 2006-01-27](https://www.keypedia.com/records/483/pharmedium-services-llc/e400ab22-f206-4d9f-a65d-6cb53f6c8ac4) — source: FDA, date: January 27, 2006

## Related Companies

- [BeOne Medicines USA, Inc.](https://www.keypedia.com/companies/beone-medicines-usa-inc/c0db89d5-6a53-40bc-8d3f-3c603e17a11d)
- [Philip NMI Raskin](https://www.keypedia.com/companies/philip-nmi-raskin/9074ba12-52ed-4918-8a4e-7fbcab7f7974)
- [Elyse S. Rafal, M.D.](https://www.keypedia.com/companies/elyse-s-rafal-md/aa8514f3-88d5-4eaf-a609-5b928a2a542c)
- [Edwin (NMI) DeJesus, M.D](https://www.keypedia.com/companies/edwin-nmi-dejesus-md/af2d7c77-421f-40cc-8600-5cca4bc4facf)
- [Sarah D. Atkinson, M.D.](https://www.keypedia.com/companies/sarah-d-atkinson-md/b30a86b0-85c7-4013-80e1-6f71c515cc3a)
- [Diamond Wipes International Inc.](https://www.keypedia.com/companies/diamond-wipes-international-inc/63483841-4266-49ee-9b80-cba08d983a13)
- [Kimball A. Johnson, M.D.](https://www.keypedia.com/companies/kimball-a-johnson-md/ee151a27-f4a7-44c5-84c5-df2f8fe5cca4)
- [AIT Biosciences](https://www.keypedia.com/companies/ait-biosciences/a74cab7a-0526-4454-85d0-0636ebf785c3)
- [Robert Litman, M.D.](https://www.keypedia.com/companies/robert-litman-md/f4a2d872-0435-4df3-9949-2fda169fc6c3)
- [Daiichi Sankyo, Inc.](https://www.keypedia.com/companies/daiichi-sankyo-inc/fd789c74-6b2b-43fb-800d-326eceeb1aea)

## Related Officers

- [Mình D. Phan](https://www.keypedia.com/people/minh-d-phan/41f2b9c7-1c26-4f83-b4d2-2ce8f29b5745)
